Randomised wait-list controlled trial of Cognitive Behavior Therapy (CBT) for Anxiety in Parkinson's disease

Not Applicable

Recruiting

• Conditions: Parkinson's disease; Anxiety; Neurological - Parkinson's disease; Mental Health - Anxiety

• Registration Number: ACTRN12616000764437
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-06-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

PD patients scoring greater than threshold on self-report Parkinson’s Anxiety Scale (PAS) (>13)

Exclusion Criteria

People with co-morbid neurological disorders, dementia identified by the referring neurologist or scoring below the cut-off for PD-dementia (<22) on the Montreal Cognitive Assessment (MoCA), and a high risk of suicide identified by neurologist or by the Mini International Neuropsychiatric Interview (MINI-Plus) suicide item.

Persons (carer or patient with Parkinson's disease) under care currently of a psychologist/psychiatrist and currently receiving psychotherapy will be excluded from the trial. Parkinson's disease patients receiving pharmacotherapy alone (e.g. antidepressant medication) will be included and noted as receiving such treatment and analysed accordingly.

Study & Design

• Study Type: Interventional
• Study Design: Not specified